Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $328.9900 (1.92%) ($319.3300 - $329.7500) on Wed. May. 8, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.04% (three month average) | RSI | 43 | Latest Price | $328.9900(1.92%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.7% a day on average for past five trading days. | Weekly Trend | REGN declines -0.9% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(58%) XLV(48%) IVW(41%) IWF(40%) QQQ(40%) | Factors Impacting REGN price | REGN will decline at least -1.02% in a week (0% probabilities). UUP(-12%) VXX(-10%) TLT(-6%) IFRA(-6%) TIP(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.02% (StdDev 2.04%) | Hourly BBV | 0 () | Intraday Trend | 3% | | | |
|
Resistance Level | $349.59 | 5 Day Moving Average | $333.78(-1.44%) | 10 Day Moving Average | $338.71(-2.87%) | 20 Day Moving Average | $349.59(-5.89%) | To recent high | -25.2% | To recent low | 1.9% | Market Cap | $34.882b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |